SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Kraft Heinz Co. engages in the manufacture and market of food and beverage products. It operates through the North America and International geographical segments. The company was founded on July 2, 2015, and is headquartered in Pittsburgh, PA.

Kraft Heinz Co

Kraft Heinz is trending as investors consider its role as a defensive, high-dividend value play amidst a broader market rotation from high-flying tech stocks. The community is actively debating the significance of its upcoming planned separation into two companies and new CEO leadership, often dismissing recent analyst downgrades as deliberate market manipulation to facilitate accumulation at lower prices. Many anticipate substantial upside and a compelling dividend yield, contrasting with ongoing concerns about competitive pressures and past performance.

JERRY (JYAI) is a Matt Furie's artistic style; it features an AI-powered content creation hub that produces community-driven video series and art.  Jerry the Turtle, created by Matt Furie, is a character inspired by Furie’s artistic style. JERRY is also an AI-driven meme coin with an ambitious vision. The goal is to establish an AI-powered production house dedicated to creating a video series or episodes featuring characters from Matt Furie’s universe alongside those from Jerry’s world.  This unique blend of characters aims to produce the ultimate crypto-based series. Additionally, we are developing an app that will offer an exclusive, ad-free video series featuring characters from both Matt Furie’s creations and the Jerry Universe. Users will be able to download and share videos directly through the platform.  But that’s not all! A special Jerry Art Panel will showcase original Jerry characters, artwork, and fan creations—free to explore, download, and share with the community.

Jerry The Turtle By Matt Furie

Jerry The Turtle ($JYAI) is gaining traction following recent exchange listings, including Bitget, and a developer update addressing selling pressure, fueling community confidence. Enthusiasts are actively discussing its potential to become the next major memecoin, drawing comparisons to $PEPE, and anticipating further Tier 1 exchange listings as part of its ambitious growth strategy.

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Henry Schein Inc.

Henry Schein is trending due to significant strategic developments, including securing exclusive US distribution rights for Curodont and rolling out new AI-powered dental workflows, which are expected to boost its Dental business. These positive catalysts are reinforced by a major strategic investment from KKR and a recent share repurchase program. The community is actively discussing how these moves, combined with recent analyst upgrades, position Henry Schein for a potential rebound within the broader MedicalTech sector.

Akamai Technologies, Inc. engages in the provision of cloud services for delivering, optimizing, and securing content and business applications over the Internet. Its products include security, web performance, media delivery, and network operator. The company was founded by Frank T. Leighton, Jonathan Seelig, Randall S. Kaplan, and Daniel M. Lewin on August 20, 1998 and is headquartered in Cambridge, MA.

Akamai Technologies Inc

Akamai Technologies is trending due to a wave of recent analyst upgrades from firms like Morgan Stanley and Guggenheim, highlighting accelerated growth in its security and cloud computing segments. The community is actively discussing Akamai's strategic pivot into AI infrastructure and edge computing, particularly its NVIDIA partnership, positioning it as a key, and potentially undervalued, player in handling evolving AI workloads.

Sutro Biopharma, Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA.

Sutro Biopharma Inc

Sutro Biopharma is a hot topic as it navigates the aftermath of a recent reverse stock split and works to maintain Nasdaq compliance. Community sentiment is sharply divided: many bulls highlight a strengthened cash runway into 2027, insider buying, and anticipated milestone payments from collaborations as catalysts for a potential rebound. However, bears express significant frustration over management's strategic "deprioritization" of its Luvelta asset, despite positive clinical data, and question the path forward for its next-generation Antibody-Drug Conjugate pipeline amid a challenging biotech landscape.

Lynas Rare Earths Ltd. engages in the production of rare earth minerals. It focuses on the exploration, development, mining, and processing of rare earth deposits. The company was founded by Nicholas Anthony Curtis on May 23, 1983 and is headquartered in Perth, Australia.

Lynas Rare Earths Limited

Lynas Rare Earths is trending as strategic partnerships and substantial US government backing highlight ongoing efforts to establish a non-Chinese rare earth supply chain. Community discussion centers on Lynas's pivotal role in global independence for critical minerals, driven by increasing demand from sectors like AI and electric vehicles, with an upcoming quarterly report anticipated to provide further insight.

Ethereum Classic

Ethereum Classic (ETC) is trending with significant community discussion, as many anticipate a major surge for the 'classic' Proof-of-Work altcoin amid broader market optimism driven by upcoming regulatory clarity and increased liquidity. Despite some frustration over its relative performance, enthusiasts are actively accumulating, viewing current price levels as a prime buying opportunity before an expected breakout.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is trending due to its recent definitive agreement to acquire Penumbra for $14.5 billion, a strategic move aiming to significantly expand its vascular medicine business. While some investors are concerned about potential integration costs, the broader community largely views BSX as an oversold, high-quality healthcare investment. This sentiment is reinforced by its strong product pipeline, including the FARAPULSE PFA system, and a history of positive financial performance, leading many to anticipate a strong recovery.

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Quant (QNT) is actively discussed as a crucial player in institutional blockchain adoption, driven by its Overledger platform powering initiatives like the UK's tokenized deposit pilot with major banks. The community anticipates significant long-term growth from QNT's limited supply and developing Quant Fusion update for multi-chain interoperability, even amidst some short-term price frustrations.

Dash (DASH) is digital cash designed to offer financial freedom to everyone. Payments are instant, easy and secure, with near-zero fees. Built to support real life use cases, Dash is the leading decentralized payment solution. Users can purchase goods at thousands of merchants and trade it at major exchanges and brokers around the globe. Since its creation in 2014, Dash has demonstrated leadership in innovation and pioneered groundbreaking features such as: -Two-tier network with incentivized nodes and decentralized project governance (Masternodes) -Instantly settled payments (InstantSend) -Instantly immutable blockchain (ChainLocks) -Optional privacy (PrivateSend)

Dash

Dash is generating significant buzz following its integration with ACH and rumored major collaborations, driving it into the top traded assets on Coinbase. The community is actively discussing its potential for a substantial rally, positioning this 'OG privacy coin' to mirror the recent strong performances seen in Zcash and Monero.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

DaVita HealthCare (DVA) Suffers a Larger Drop Than the General Market: Key Insights

DaVita HealthCare (DVA) closed the most recent trading day at $104.47, moving 5.11% from the previous trading session.

Why DaVita HealthCare (DVA) Dipped More Than Broader Market Today

DaVita HealthCare (DVA) reached $111.01 at the closing of the latest trading day, reflecting a -3.23% change compared to its last close.

DaVita (NYSE:DVA) Reaches New 1-Year Low After Analyst Downgrade

DaVita (NYSE:DVA) Hits New 1-Year Low Following Analyst Downgrade...

Truist Financial Cuts DaVita (NYSE:DVA) Price Target to $128.00

Truist Financial reduced their price target on shares of DaVita from $140.00 to $128.00 and set a "hold" rating for the company in a research report on Monday...

DaVita Inc. $DVA Shares Sold by Voya Investment Management LLC

Voya Investment Management LLC lowered its holdings in DaVita Inc. (NYSE:DVA - Free Report) by 63.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange...

Abacus FCF Advisors LLC Sells 23,857 Shares of DaVita Inc. $DVA

Abacus FCF Advisors LLC trimmed its stake in DaVita Inc. (NYSE:DVA - Free Report) by 60.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange...

DaVita (NYSE:DVA) Sets New 1-Year Low - Here's What Happened

DaVita (NYSE:DVA) Reaches New 52-Week Low - Here's Why...

DaVita HealthCare (DVA) Beats Stock Market Upswing: What Investors Need to Know

In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $116.51, denoting a +1.14% move from the preceding trading day.

Zacks Industry Outlook Highlights Encompass Health, DaVita, Option Care Health and The Pennant

Encompass Health is in focus as outpatient and home healthcare shifts toward AI, telehealth and cost-efficient care models.

Wedge Capital Management L L P NC Has $33.34 Million Position in DaVita Inc. $DVA

Wedge Capital Management L L P NC trimmed its holdings in DaVita Inc. (NYSE:DVA - Free Report) by 6.5% during the third quarter, according to its most recent 13F filing with the Securities and...

DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

Current Price	$104.85
Prev Close	$105.84
Open	$104.94
Dividend Yield	0.00%
50-Day Moving Average	$116.47
Beta	0.54
Avg. Volume	739,397.32
PE Ratio	10.78

52-Week High	$179.60
52-Week Low	$101.00
Market Capitalization	$8.21B
EPS (Annual)	$10.73
Price to Book	-13.00
Revenue Per Employee	$168,625.66
Enterprise Value/EBITDA	N/A

DVA
DaVita Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest DVA News

DVADaVita Inc